Growth of children with isolated Robin sequence treated by nasopharyngeal intubation: importance of a hypercaloric diet.
OBJECTIVE
To compare the growth curves (weight and length) of two groups of infants with isolated Robin sequence (RS) treated with nasopharyngeal intubation (NPI), one group receiving a hypercaloric diet and the other receiving a normal diet for age, and compare the growth rates and duration of NPI between the two groups.


METHODS
Prospective longitudinal study.


METHODS
Hospital de Reabilitação de Anomalias Craniofaciais, Universidade de São Paulo, Bauru, Brazil, 1998 to 2000.


METHODS
Twenty-three children with isolated RS treated by prolonged NPI.


METHODS
Nine children received a milk formula supplemented with 5% to 7% glucose polymers and 3% to 5% medium chain triglycerides (group 1), and 14 children received a milk formula only (group 2). Weight and length were measured at birth and every month up to 6 months of life for the construction of weight and length growth curves. The time of use of the nasogastric tube, age at the beginning of NPI, and duration of NPI were also determined.


RESULTS
No significant difference in length was observed between the two groups. The mean weight curves obtained for the two groups were below the 50th percentile of the National Center for Health Statistics, but weight gain was higher in group 1. The duration of NPI was shorter in this group.


CONCLUSIONS
The hypercaloric diet led to an improvement in nutritional status, which in turn contributed to improved respiratory conditions in isolated RS.
Marques
Ilza Lazarini
IL
Unidade de Ensino e Pesquisa, Hospital de Reabilitação de Anomalias Craniofaciais, Universidade de São Paulo, Bauru, São Paulo, Brazil. ilza_marques@uol.com.br
Peres
Suely Prieto de Barros Almeida
SP
Bettiol
Heloisa
H
Barbieri
Marco Antonio
MA
Andrea
Mauro
M
De Souza
Luiz
L
D000402:Airway Obstruction / Q000209:etiology / Q000628:therapy; D001827:Body Height; D001835:Body Weight; D002149:Energy Intake; D004750:Enteral Nutrition / Q000379:methods*; D006128:Growth; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007441:Intubation, Gastrointestinal; D010855:Pierre Robin Syndrome / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D011446:Prospective Studies